Wu Zhaoting, Tang Lihua, Lai Yaozhen, Liu Muyuan, Zhou Li
Department of Gynecologic Oncology, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, People's Republic of China.
Department of Gynecology, the First People's Hospital of Chenzhou, Chenzhou, Hunan, People's Republic of China.
Int J Womens Health. 2024 Jul 1;16:1187-1198. doi: 10.2147/IJWH.S454119. eCollection 2024.
Struma ovarii is a highly specialized teratoma consisting primarily of mature thyroid tissue. However, malignant struma ovarii coexisting with thyroid carcinoma, not to mention autoimmune disease, is uncommon. Malignant struma ovarii complicated with papillary thyroid carcinoma, Hashimoto's thyroiditis and polycystic ovarian syndrome has never been reported in literature.
A 32-year-old female was admitted to our hospital due to a history of abdominal distension and menolipsis over the past half a year. Physical examination touched a 6 × 6 cm mass with a clear boundary, normal movement, and no pressing pain in the right adnexal area, Imaging revealed a cystic solid mass of 6 × 7 cm in the right ovary and the level of tumor markers including CA125, CA199, CA153, CEA, AFP were normal, but with low TSH and increased TPOAb, TGAb, TRAb. Laparoscopic right ovary tumor resection was performed, followed by comprehensive staging surgery, as well as thyroidectomy after pathologic diagnosis. The patient was diagnosed with a combination of follicular thyroid cancer from struma ovarii, papillary thyroid carcinoma and Hashimoto's thyroiditis, along with polycystic ovarian syndrome. Immunohistochemical staining showed positivity for Ag, CK-pan, CK7, PAX8 and TTF-1 in the right ovarian mass, and the left thyroid was positive for the BRAF V600E mutation.
The patient underwent thyroxine suppression therapy and radioactive iodine I therapy after operation. Serum thyroglobulin was undetectable, and no signs of recurrence or metastasis were detected in the imaging examination at the 2-year follow-up.
Malignant struma ovarii coexisting with thyroid carcinoma is rare. No report has been identified in literature review on the rare malignant struma ovarii coexisting with thyroid carcinoma, Hashimoto's thyroiditis and polycystic ovarian syndrome. Our case can offer experience of diagnosis and treatment to some extent for such rare case. Therefore, it is essential to consider the association between ovarian tumors and the endocrine system. This case is valuable in understanding the diagnosis and management of such an unusual complicated disease.
卵巢甲状腺肿是一种高度特殊的畸胎瘤,主要由成熟甲状腺组织构成。然而,恶性卵巢甲状腺肿与甲状腺癌并存,更不用说与自身免疫性疾病并存,这种情况并不常见。恶性卵巢甲状腺肿合并乳头状甲状腺癌、桥本甲状腺炎和多囊卵巢综合征的情况在文献中从未有过报道。
一名32岁女性因过去半年腹胀和闭经病史入院。体格检查在右附件区触及一个6×6cm的肿块,边界清晰,活动正常,无压痛。影像学检查显示右卵巢有一个6×7cm的囊实性肿块,肿瘤标志物CA125、CA199、CA153、CEA、AFP水平正常,但促甲状腺激素水平低,甲状腺过氧化物酶抗体、甲状腺球蛋白抗体、促甲状腺激素受体抗体升高。行腹腔镜下右卵巢肿瘤切除术,随后进行全面分期手术,并在病理诊断后行甲状腺切除术。该患者被诊断为卵巢甲状腺肿合并滤泡性甲状腺癌、乳头状甲状腺癌和桥本甲状腺炎,以及多囊卵巢综合征。免疫组化染色显示右卵巢肿块中Ag、细胞角蛋白广谱、细胞角蛋白7、配对盒基因8和甲状腺转录因子-1呈阳性,左甲状腺BRAF V600E突变呈阳性。
患者术后接受甲状腺素抑制治疗和放射性碘I治疗。血清甲状腺球蛋白检测不到,在2年随访的影像学检查中未发现复发或转移迹象。
恶性卵巢甲状腺肿与甲状腺癌并存罕见。文献综述中未发现关于罕见的恶性卵巢甲状腺肿与甲状腺癌、桥本甲状腺炎和多囊卵巢综合征并存的报道。我们的病例在一定程度上可为这种罕见病例提供诊断和治疗经验。因此,必须考虑卵巢肿瘤与内分泌系统之间的关联。该病例对于理解这种不寻常的复杂疾病的诊断和管理具有重要价值。